Germany vs Malaysia: HIV/AIDS deaths averted by antiretroviral therapy
Germany
2,906 deaths
in 2024
Malaysia
2,430 deaths
in 2024
Germany rank
51st
Malaysia rank
52nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Germany
- Malaysia
How they compare
Germany currently reports 2,906 deaths against 2,430 deaths in Malaysia, a difference of 476 deaths.
That makes Germany's figure about 1.2 times Malaysia's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Malaysia ahead.
Germany ranks 51st and Malaysia ranks 52nd of 157 countries.
Germany has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Germany | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1,195 deaths | 2.35 deaths | 1,193 deaths | Germany |
| 2000s | 2,173 deaths | 917.24 deaths | 1,256 deaths | Germany |
| 2010s | 2,484 deaths | 1,987 deaths | 496.6 deaths | Germany |
| 2020s | 2,825 deaths | 2,627 deaths | 198.77 deaths | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Germany or Malaysia?
- Germany, at 2,906 deaths against 2,430 deaths in Malaysia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Germany and Malaysia?
- 476 deaths, with Germany ahead.
- How many years of comparable data are there for Germany and Malaysia?
- 35 years are reported by both, from 1990 to 2024.
- How do Germany and Malaysia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Germany ranks 51st and Malaysia ranks 52nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.